Key result
Intravenous indomethacin caused a 40% decrease in retrograde flow and a 20% decrease in microvascular collateral flow in dogs with well-developed coronary collateral vessels.
Why the study?
Does indomethacin reduce blood flow through well-developed coronary collateral vessels in a dog model of coronary occlusion?
Does indomethacin reduce blood flow through well-developed coronary collateral vessels in a dog model of coronary occlusion?
Cyclooxygenase blockade with indomethacin significantly reduces blood flow through well-developed coronary collateral vessels, indicating they are under tonic influence of vasodilator prostaglandins.
Answers are grounded in this paper and cite their sources.
Indomethacin may impair collateral perfusion in canine models; leaves open relevance to human coronary disease.
Collateral vessels that develop after coronary artery occlusion demonstrate perivascular inflammation, subintimal hyperplasia, and endothelial proliferation. This study was performed to test the hypothesis that these abnormalities are associated with evidence for increased production of vasodilator prostaglandins. Eight dogs were studied 4-6 months after occlusion of the anterior descending coronary artery had been performed to stimulate collateral vessel growth. At the time of study, the anterior descending coronary artery was cannulated at the site of occlusion to allow measurement of retrograde blood flow as an index of interarterial collateral flow. Injection of radioactive microspheres during the retrograde flow collection allowed determination of continuing tissue flow in the collateral-dependent zone as an index of intramural microvascular collateral flow. Retrograde and tissue flows were measured before and 20 minutes after 5 mg/kg i.v. indomethacin, a dose that caused 95 +/- 3% inhibition of the coronary vasodilation in response to a 500 micrograms intracoronary bolus of arachidonic acid. Heart rate and mean aortic pressure were not significantly altered by indomethacin, and blood flow to the normally perfused myocardial region was not changed by administration of indomethacin. However, indomethacin caused a 40 +/- 7% decrease in retrograde flow (p less than 0.01), and microvascular collateral flow to the dependent myocardium decreased by 20 +/- 10% (p less than 0.05). These data indicate that, unlike the normal coronary circulation, well-developed coronary collateral vessels are under the tonic influence of vasodilator prostaglandins.
No takes yet. Share an insight, caveat, or question.
Altman et al. (1992) studied Coronary collateral vessels after coronary artery occlusion (n=8). Indomethacin vs. Baseline (before administration) was evaluated on Retrograde blood flow and microvascular collateral flow (p=<0.01). Intravenous indomethacin caused a 40% decrease in retrograde flow and a 20% decrease in microvascular collateral flow in dogs with well-developed coronary collateral vessels.
Synapse has enriched 10 related papers. Consider them for comparative context: